Targeting MCL-1 in hematologic malignancies: Rationale and progress-Reference-Cited by-同舟云学术

Targeting MCL-1 in hematologic malignancies: Rationale and progress

Published:2020-11 Issue: Volume:44 Page:100672
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Wei Andrew H.,Roberts Andrew W.,Spencer Andrew,Rosenberg Aaron Seth,Siegel David,Walter Roland B.,Caenepeel Sean,Hughes Paul,McIver Zach,Mezzi Khalid,Morrow Phuong Khanh,Stein Anthony

Funder

Amgen Inc

UC Davis Paul Calabresi Career Development Award for Clinical Oncology

National Cancer Institute/National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference140 articles.

1. Bcl-2 proteins in development, health, and disease of the hematopoietic system;Kollek;FEBS J,2016

2. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy;Czabotar;Nat Rev Mol Cell Biol,2014

3. Emerging role of Mcl-1 in actively counteracting BH3-only proteins in apoptosis;Zhuang;Cell Death Differ,2006

4. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo;Carrington;Cell Death Differ,2017

5. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function;Chen;Mol Cell,2005

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression patterns of eighteen genes involved in crucial cellular processes in the TP53 pathway in Multiple Myeloma;Gazi University Journal of Science;2024-09-01

2. CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulator;Cell Death & Disease;2024-08-27

3. Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation;Heliyon;2024-07

4. Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status;Blood Advances;2024-06-28

5. Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-25